tofacitinib and Fever

tofacitinib has been researched along with Fever* in 1 studies

Other Studies

1 other study(ies) available for tofacitinib and Fever

ArticleYear
Successful treatment of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome with tofacitinib.
    Pediatric dermatology, 2021, Volume: 38, Issue:2

    Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome is a rare autoinflammatory disorder. Cutaneous manifestations of CANDLE syndrome include characteristic recurring violaceous annular plaques comprised of an immature dermal mononuclear cell infiltrate. In CANDLE syndrome, deleterious genetic mutations inhibit proteasome-immunoproteasome function, resulting in cellular accumulation of ubiquitinated waste proteins that activate type I interferon signaling to drive inflammation. We describe a report of successful treatment of a 12-year-old girl with CANDLE syndrome with tofacitinib.

    Topics: Child; Female; Fever; Humans; Immunologic Deficiency Syndromes; Lipodystrophy; Piperidines; Pyrimidines; Skin Diseases; Sweet Syndrome

2021